| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Chief Financial Officer
1 company
Pizzie Nick serves as a Chief Financial Officer at AXSM. Across recent SEC filings that breaks down to 11 buys and 4 sells. Those positions are worth an estimated $266K at current prices.
Historically, Pizzie Nick's trades have earned a middling insider score of 50/100 across 3 rated trades. Over a 12-month horizon, 33.3% of those trades were profitable, with an average 12-month return of -6.0%.
The biggest single holding is AXSM (~$266K) as Chief Financial Officer. The recent filings there lean toward selling, a net 17,768 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 9, 2026 | AXSM Axsome Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 33,000 | $240.09 | $7,922,970.00 | -43.5% | -15.4% | - | |
| Jan 22, 2026 | AXSM Axsome Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 12,000 | $187.92 | $2,255,040.00 | -22.0% | -0.3% | - | |
| Feb 14, 2025 | AXSM Axsome Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 15,000 | $130.10 | $1,951,530.00 | -26.2% | -18.2% | +38.2% | |
| Nov 18, 2021 | AXSM Axsome Therapeutics, Inc. | Chief Financial Officer | Buy | 955 | $35.26 | $33,676.03 | -117.5% | -11.2% | +57.8% | |
| Jun 29, 2020 | AXSM Axsome Therapeutics, Inc. | Chief Financial Officer | Buy | 777 | $76.64 | $59,549.28 | +1.9% | - | - | |
| Sep 26, 2019 | AXSM Axsome Therapeutics, Inc. | Chief Financial Officer | Buy | 2,180 | $24.80 | $54,064.00 | +5.7% | - | - | |
| Jun 11, 2019 | AXSM Axsome Therapeutics, Inc. | Chief Financial Officer | Buy | 1,920 | $20.80 | $39,936.00 | New | - | - | |
| Mar 19, 2019 | AXSM Axsome Therapeutics, Inc. | Chief Financial Officer | Buy | 5,400 | $12.58 | $67,938.60 | +17.5% | - | - | |
| Jun 19, 2018 | AXSM Axsome Therapeutics, Inc. | Chief Financial Officer | Buy | 31,000 | $3.10 | $96,080.00 | New | - | - |